Abstract
BackgroundAntiplatelet agents reduce recurrence after cerebral ischaemia but are not effective in all patients, in part because of treatment resistance. The primary aim was to assess the proportion of patients...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have